Economic Scene – Weak Rules in U.S. on Toxins and Consumer Safety – NYTimes.com

Posted by Trish Riley, April 21, 2010

“…the evidence has become strong enough that last month GlaxoSmithKline — which also makes Tums, Nicorette and the country’s top-selling asthma drug — stopped making the version of Poligrip with zinc, after having previously resisted just such a move. In Japan, responding to regulators’ concerns, the company has also recalled from stores any remaining zinc-infused cream.All of which makes you wonder: did it have to come this?Every society needs to make a choice about how to prioritize consumer safety.

“We are not taking toxic risks seriously enough.”

via Economic Scene – Weak Rules in U.S. on Toxins and Consumer Safety – NYTimes.com.